6 results
the primary objective of our study is to define a set of patient characteristics that can predict the effectiveness of an MRA in treating symptomatic OSA. The aim of our study is to develop a prediction model to calculate the success rate in an…
Sleep Medicine Center Kempenhaeghe has a unique opportunity to combine clinical PSG with different advanced non-invasive sleep monitoring techniques as mentioned in the former paragraph. In the center, data are currently obtained in a cohort of…
The purpose of this study is to compare the taste of JZP-258 to placebo (a medicine without any active ingredient or fake medicine) for sameness. This is to ensure that when used in other studies, subjects will not taste a difference between both…
FT218 is a new formulation (composition) of the registered drug sodium oxybate. Sodium oxybate (also known as the sodium salt of gamma-hydroxybutyric acid [GHB]) is registered under the name Xyrem® for the treatment of narcolepsy.The purpose of this…
FT218 is a new formulation of the drug sodium oxybate (also known as the sodium salt of gamma-hydroxybutyric acid [GHB]), a registered drug under the tradename Xyrem® for the treatment of narcolepsy. FT218 has been administered to humans before.The…
We will evaluate the effects of video consultation versus face-to-face and consultations by telephone for patients with sleep apnea in terms of patients* CPAP treatment self-efficacy (primary outcome). Also the effects on risk perception, outcome…